Sales & Marketing | Connecting with physicians and patients

News

FDA hands another rejection to Replimune's melanoma therapy

Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, prompting job losses.

News

Senju launches first-in-class dry eye disease drug in Japan

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

News

CT-155, and Boehringer Ingelheim and Click Therapeutics logos

Boehringer transfers schizophrenia DTx selling rights to Cli...

Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.

News

A pharmacy prescriptions counter in shadow

AbbVie tries a new approach in 340B programme battle

AbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.

Sales & Marketing

How war in the Middle East is disrupting medical supply chai...

The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.

News

MSD adds new indication for Welireg in rare tumours

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare solid tumour PPGL or 'pheo para'.

News

AbbVie bags first approval for cancer ADC Emrelis

AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis.

News

Sanofi pledges a $20 billion investment programme in the US

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.

News

FDA hands another rejection to Replimune's melanoma therapy

Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, prompting job losses.

News

Senju launches first-in-class dry eye disease drug in Japan

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Press Releases

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

Sales & Marketing

Partner Content

Pharma Equipment Auction: Surepharm Assets Sale

Bid on used pharmaceutical production and packaging equipment. View auction April 22-24.

Views & Analysis

Sales & Marketing

How war in the Middle East is disrupting medical supply chai...

The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.

Sales & Marketing

Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Deep Dive

Sales & Marketing

Deep Dive: Commercialisation 2024

In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.

Sales & Marketing

Five top tips for developing a communication strategy

Sales & Marketing

Assessing the global applicability of the UK’s ‘Netflix’-sty...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Sales & Marketing

Sponsored

Health Trends 2025: Reimagining What's Possible

Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl

Podcasts

Sales & Marketing

Sponsored

From Buzzword to Strategy: Reverba Global Talks Omnichannel ...

Sales & Marketing

pharmaphorum podcast Episode 243, Lisa Sims, Novartis

On quality data for quality learnings, with Lisa Sims

Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & operations at Novartis, about personalising learning at scale.

Sales & Marketing

pharmaphorum podcast Episode 212, Bayer and Veeva

Collaborating on a connected platform journey, with Alexande...

pharmaphorum speaks with Bayer's Alexander Alex and Veeva's Florian Schnappauf about Bayer's recent migration to the connected Vault CRM platform.

Video

Sales & Marketing

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Sales & Marketing

Sponsored

Bridging science and strategy: Medical Affairs at the heart ...

In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.

White Papers

Sales & Marketing

Sponsored

What HCPs Say Pharma Gets Wrong About Survey Research

Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.

Sales & Marketing

Lumanity white paper - person at top of mountain range

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Sales & Marketing

Sponsored

5 strategies to retain top talent

The pharma sales industry is in the midst of rapid transformation, fuelled by digital disruption and dynamic market forces.

Event

Sales & Marketing

Partner Content

The ESG in Life Sciences Summit is coming to the West Coast!

The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).

Sales & Marketing

Reuters Pharma Barcelona 2023 - Day 2

Moving into Day Two – if you missed it, do be sure to catch up on yesterday’s coverage here – pharmaphoru

Debates & Insight

Sponsored

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Sales & Marketing

Sponsored

An integrated CRM saves time, money and drives sales efficie...

Like most pharmaceutical companies, Théa Pharma places the utmost importance on quality customer data – but non-integrated systems were holding the team back.

Debates & Insight